MX2020008392A - Parches que comprenden urushiol, paneles de prueba que comprenden los mismos, y sus metodos de uso. - Google Patents

Parches que comprenden urushiol, paneles de prueba que comprenden los mismos, y sus metodos de uso.

Info

Publication number
MX2020008392A
MX2020008392A MX2020008392A MX2020008392A MX2020008392A MX 2020008392 A MX2020008392 A MX 2020008392A MX 2020008392 A MX2020008392 A MX 2020008392A MX 2020008392 A MX2020008392 A MX 2020008392A MX 2020008392 A MX2020008392 A MX 2020008392A
Authority
MX
Mexico
Prior art keywords
urushiol
same
patches
test panels
methods
Prior art date
Application number
MX2020008392A
Other languages
English (en)
Inventor
Waseem Gul
Curt Hamann
Mahmoud Ahmed Elsohly
Raymond J Hage
Original Assignee
Hapten Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hapten Sciences Inc filed Critical Hapten Sciences Inc
Publication of MX2020008392A publication Critical patent/MX2020008392A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En este documento se describen parches epicutáneos que contienen urushiol que comprenden un material de soporte y una película que contiene urushiol en una superficie del material de soporte. Una superficie del material de soporte se recubre con la película que contiene urushiol. También se describen en este documento paneles de prueba que comprenden parches epicutáneos que contienen urushiol de contenido variable de urushiol. Los paneles de prueba pueden emplearse en métodos para evaluar la sensibilidad del sujeto al urushiol, para determinar una relación de respuesta a las dosis a las dosis variables de urushiol y para evaluar la eficacia de los tratamientos para prevenir o inhibir la dermatitis de contacto inducida por urushiol en un sujeto.
MX2020008392A 2018-02-13 2019-02-13 Parches que comprenden urushiol, paneles de prueba que comprenden los mismos, y sus metodos de uso. MX2020008392A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862630151P 2018-02-13 2018-02-13
PCT/US2019/017835 WO2019160942A1 (en) 2018-02-13 2019-02-13 Patches comprising urushiol, test panels comprising the same, and methods of using the same

Publications (1)

Publication Number Publication Date
MX2020008392A true MX2020008392A (es) 2020-12-07

Family

ID=67619571

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008392A MX2020008392A (es) 2018-02-13 2019-02-13 Parches que comprenden urushiol, paneles de prueba que comprenden los mismos, y sus metodos de uso.

Country Status (5)

Country Link
US (2) US11666667B2 (es)
JP (1) JP7326343B2 (es)
CA (1) CA3091168A1 (es)
MX (1) MX2020008392A (es)
WO (1) WO2019160942A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409908A (en) 1993-10-20 1995-04-25 Vyrex Corporation Complexing urushiols
AU770464B2 (en) 1998-12-22 2004-02-19 Seer Pharmaceuticals, Llc Treatment of skin lesions
FR2822049B1 (fr) * 2001-03-13 2003-08-01 Dbv Medica 1 Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
WO2009146131A2 (en) 2008-04-03 2009-12-03 The University Of Mississippi Compositions for prevention/prophylactic treatment of poison ivy dermatitis
CN103479400A (zh) 2012-06-11 2014-01-01 浙江我武生物科技股份有限公司 一种含有漆酚的皮炎诊断贴剂及其制备方法

Also Published As

Publication number Publication date
US20200405886A1 (en) 2020-12-31
WO2019160942A1 (en) 2019-08-22
US20240100195A1 (en) 2024-03-28
CA3091168A1 (en) 2019-08-22
JP7326343B2 (ja) 2023-08-15
JP2021513565A (ja) 2021-05-27
US11666667B2 (en) 2023-06-06

Similar Documents

Publication Publication Date Title
CL2018000514A1 (es) Artículo para uso con aparato para calentar material para fumar.
EP4397350A3 (en) Medical device stabilizing apparatus and method of use
EP4038520A4 (en) METHODS AND APPARATUS FOR ATTESTING OBJECTS IN PERIPHERAL COMPUTER ENVIRONMENTS
EA202192744A3 (ru) Фунгицидные комбинации
PH12020550936A1 (en) Combination drug including tlr7 agonist
BR112017023576A2 (pt) Método para tratar uma disfunção proliferativa de células b
GB2543194A (en) Thin film coating on mechanical face seals
TW201614285A (en) Circular polarizing plate, wideband [lambda]/4 plate, and organic electroluminescence display device
EP3787070A4 (en) POSITIVE ELECTRODE PART AND ELECTROCHEMICAL DEVICE
EP3787072A4 (en) ELECTRODE PLATE AND ELECTROCHEMICAL DEVICE
EP3468565A4 (en) USE OF MI R-198 FOR THE TREATMENT AND DIAGNOSIS OF SKIN PLATEN CARCINOMA
WO2014093405A3 (en) Preserving layout of region of content during modification
TW201611946A (en) Modifying substrate thickness profiles
MY189213A (en) Elastic roller
MX2020008392A (es) Parches que comprenden urushiol, paneles de prueba que comprenden los mismos, y sus metodos de uso.
PH12018502688A1 (en) A skin-friendly absorbent structure for providing oxygen
EP4233928A3 (en) Nanoreservoirs
MX2018002828A (es) Plataforma de trabajo y metodo de uso de las misma.
ECSP099069A (es) Fertilizante seco con formulación que contiene hormona de crecimiento y métodos para su uso y fabricación
EP3783695A4 (en) POSITIVE ELECTRODE PART AND ELECTROCHEMICAL DEVICE
WO2019068292A8 (en) Load cell lift-off protection device
SG11201807452UA (en) Protective film-forming composite sheet
ZA202108217B (en) Lipid-based nanoparticles and use of same in optimized insulin dosing regimens
MX2022008551A (es) Formulacion liquida que comprende paeonol y apocinina.
WO2020081730A3 (en) Nutlin-3a for use in treating a mycobacterium tuberculosis infection